Logo image of CPSS

CONSUMER PORTFOLIO SERVICES (CPSS) Stock Fundamental Analysis

USA - NASDAQ:CPSS - US2105021008 - Common Stock

8.2 USD
+0.19 (+2.37%)
Last: 10/23/2025, 10:27:50 AM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CPSS. CPSS was compared to 55 industry peers in the Consumer Finance industry. CPSS has a bad profitability rating. Also its financial health evaluation is rather negative. CPSS may be a bit undervalued, certainly considering the very reasonable score on growth


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year CPSS was profitable.
In the past year CPSS had a positive cash flow from operations.
CPSS had positive earnings in each of the past 5 years.
Each year in the past 5 years CPSS had a positive operating cash flow.
CPSS Yearly Net Income VS EBIT VS OCF VS FCFCPSS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

1.2 Ratios

The Return On Assets of CPSS (0.52%) is worse than 63.64% of its industry peers.
The Return On Equity of CPSS (6.41%) is comparable to the rest of the industry.
CPSS's Return On Invested Capital of 0.21% is in line compared to the rest of the industry. CPSS outperforms 43.64% of its industry peers.
CPSS had an Average Return On Invested Capital over the past 3 years of 1.36%. This is significantly below the industry average of 10.98%.
Industry RankSector Rank
ROA 0.52%
ROE 6.41%
ROIC 0.21%
ROA(3y)1.75%
ROA(5y)1.69%
ROE(3y)20.24%
ROE(5y)20.98%
ROIC(3y)1.36%
ROIC(5y)1.73%
CPSS Yearly ROA, ROE, ROICCPSS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

Looking at the Profit Margin, with a value of 4.79%, CPSS is doing worse than 69.09% of the companies in the same industry.
CPSS's Profit Margin has improved in the last couple of years.
CPSS has a worse Operating Margin (2.70%) than 61.82% of its industry peers.
CPSS's Operating Margin has declined in the last couple of years.
CPSS has a Gross Margin (46.69%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of CPSS has declined.
Industry RankSector Rank
OM 2.7%
PM (TTM) 4.79%
GM 46.69%
OM growth 3Y-59.4%
OM growth 5Y-8.29%
PM growth 3Y-33.4%
PM growth 5Y26.98%
GM growth 3Y-12.4%
GM growth 5Y-6.49%
CPSS Yearly Profit, Operating, Gross MarginsCPSS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CPSS is destroying value.
The number of shares outstanding for CPSS has been increased compared to 1 year ago.
CPSS has less shares outstanding than it did 5 years ago.
CPSS has a worse debt/assets ratio than last year.
CPSS Yearly Shares OutstandingCPSS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
CPSS Yearly Total Debt VS Total AssetsCPSS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of 0.24, we must say that CPSS is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.24, CPSS is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
CPSS has a debt to FCF ratio of 12.79. This is a negative value and a sign of low solvency as CPSS would need 12.79 years to pay back of all of its debts.
CPSS has a Debt to FCF ratio (12.79) which is in line with its industry peers.
CPSS has a Debt/Equity ratio of 11.20. This is a high value indicating a heavy dependency on external financing.
CPSS has a Debt to Equity ratio of 11.20. This is amonst the worse of the industry: CPSS underperforms 83.64% of its industry peers.
Industry RankSector Rank
Debt/Equity 11.2
Debt/FCF 12.79
Altman-Z 0.24
ROIC/WACC0.04
WACC5.16%
CPSS Yearly LT Debt VS Equity VS FCFCPSS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

A Current Ratio of 0.26 indicates that CPSS may have some problems paying its short term obligations.
CPSS has a worse Current ratio (0.26) than 69.09% of its industry peers.
A Quick Ratio of 0.26 indicates that CPSS may have some problems paying its short term obligations.
CPSS has a worse Quick ratio (0.26) than 69.09% of its industry peers.
Industry RankSector Rank
Current Ratio 0.26
Quick Ratio 0.26
CPSS Yearly Current Assets VS Current LiabilitesCPSS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

6

3. Growth

3.1 Past

The earnings per share for CPSS have decreased strongly by -25.62% in the last year.
Measured over the past years, CPSS shows a very strong growth in Earnings Per Share. The EPS has been growing by 29.11% on average per year.
The Revenue has grown by 16.13% in the past year. This is quite good.
Measured over the past years, CPSS shows a small growth in Revenue. The Revenue has been growing by 1.50% on average per year.
EPS 1Y (TTM)-25.62%
EPS 3Y-24.58%
EPS 5Y29.11%
EPS Q2Q%3.01%
Revenue 1Y (TTM)16.13%
Revenue growth 3Y11.02%
Revenue growth 5Y1.5%
Sales Q2Q%21.45%

3.2 Future

CPSS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 47.53% yearly.
The Revenue is expected to grow by 13.90% on average over the next years. This is quite good.
EPS Next Y10.59%
EPS Next 2Y47.53%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year13.48%
Revenue Next 2Y13.9%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CPSS Yearly Revenue VS EstimatesCPSS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
CPSS Yearly EPS VS EstimatesCPSS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2024 2025 2026 0.5 1 1.5

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 10.25, the valuation of CPSS can be described as very reasonable.
CPSS's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.57, CPSS is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 4.35, the valuation of CPSS can be described as very cheap.
Based on the Price/Forward Earnings ratio, CPSS is valued cheaper than 87.27% of the companies in the same industry.
CPSS's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.09.
Industry RankSector Rank
PE 10.25
Fwd PE 4.35
CPSS Price Earnings VS Forward Price EarningsCPSS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CPSS is valued a bit more expensive than the industry average as 61.82% of the companies are valued more cheaply.
CPSS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CPSS is cheaper than 98.18% of the companies in the same industry.
Industry RankSector Rank
P/FCF 0.69
EV/EBITDA 299.28
CPSS Per share dataCPSS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

CPSS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CPSS's earnings are expected to grow with 47.53% in the coming years.
PEG (NY)0.97
PEG (5Y)0.35
EPS Next 2Y47.53%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CPSS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CONSUMER PORTFOLIO SERVICES

NASDAQ:CPSS (10/23/2025, 10:27:50 AM)

8.2

+0.19 (+2.37%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryConsumer Finance
Earnings (Last)08-11 2025-08-11/amc
Earnings (Next)10-28 2025-10-28
Inst Owners24.34%
Inst Owner Change-0.01%
Ins Owners30.57%
Ins Owner Change5.69%
Market Cap182.20M
Revenue(TTM)405.52M
Net Income(TTM)19.43M
Analysts85.71
Price Target15.3 (86.59%)
Short Float %2.22%
Short Ratio12.12
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-31.25%
Min EPS beat(2)-37.91%
Max EPS beat(2)-24.59%
EPS beat(4)0
Avg EPS beat(4)-23.22%
Min EPS beat(4)-37.91%
Max EPS beat(4)-6.63%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.29%
Min Revenue beat(2)-4.74%
Max Revenue beat(2)-1.84%
Revenue beat(4)2
Avg Revenue beat(4)-1.37%
Min Revenue beat(4)-4.74%
Max Revenue beat(4)0.85%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-19.35%
EPS NY rev (1m)0%
EPS NY rev (3m)-19.66%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.91%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.24%
Valuation
Industry RankSector Rank
PE 10.25
Fwd PE 4.35
P/S 0.45
P/FCF 0.69
P/OCF 0.68
P/B 0.6
P/tB 0.6
EV/EBITDA 299.28
EPS(TTM)0.8
EY9.76%
EPS(NY)1.89
Fwd EY23.01%
FCF(TTM)11.94
FCFY145.61%
OCF(TTM)11.98
OCFY146.04%
SpS18.25
BVpS13.64
TBVpS13.64
PEG (NY)0.97
PEG (5Y)0.35
Graham Number15.67
Profitability
Industry RankSector Rank
ROA 0.52%
ROE 6.41%
ROCE 0.3%
ROIC 0.21%
ROICexc 0.21%
ROICexgc 0.22%
OM 2.7%
PM (TTM) 4.79%
GM 46.69%
FCFM 65.43%
ROA(3y)1.75%
ROA(5y)1.69%
ROE(3y)20.24%
ROE(5y)20.98%
ROIC(3y)1.36%
ROIC(5y)1.73%
ROICexc(3y)1.37%
ROICexc(5y)1.74%
ROICexgc(3y)1.38%
ROICexgc(5y)1.76%
ROCE(3y)1.89%
ROCE(5y)2.4%
ROICexgc growth 3Y-61.84%
ROICexgc growth 5Y-12.69%
ROICexc growth 3Y-61.73%
ROICexc growth 5Y-12.61%
OM growth 3Y-59.4%
OM growth 5Y-8.29%
PM growth 3Y-33.4%
PM growth 5Y26.98%
GM growth 3Y-12.4%
GM growth 5Y-6.49%
F-Score5
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 11.2
Debt/FCF 12.79
Debt/EBITDA 285.63
Cap/Depr 83.55%
Cap/Sales 0.19%
Interest Coverage 0.05
Cash Conversion 2239.79%
Profit Quality 1365.35%
Current Ratio 0.26
Quick Ratio 0.26
Altman-Z 0.24
F-Score5
WACC5.16%
ROIC/WACC0.04
Cap/Depr(3y)82.49%
Cap/Depr(5y)73.03%
Cap/Sales(3y)0.32%
Cap/Sales(5y)0.34%
Profit Quality(3y)662.42%
Profit Quality(5y)700.15%
High Growth Momentum
Growth
EPS 1Y (TTM)-25.62%
EPS 3Y-24.58%
EPS 5Y29.11%
EPS Q2Q%3.01%
EPS Next Y10.59%
EPS Next 2Y47.53%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)16.13%
Revenue growth 3Y11.02%
Revenue growth 5Y1.5%
Sales Q2Q%21.45%
Revenue Next Year13.48%
Revenue Next 2Y13.9%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-25.84%
EBIT growth 3Y-54.92%
EBIT growth 5Y-6.91%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y23%
FCF growth 3Y5.95%
FCF growth 5Y1.55%
OCF growth 1Y22.68%
OCF growth 3Y5.65%
OCF growth 5Y1.52%